BMJ1d
POS0107 IDENTIFICATION OF POTENTIAL GENES AND TREATMENT RESPONSE TO TOFACITINIB THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
3 Institute for Medical Research, National Institutes of Health Complex, Allergy and Immunology Research Center, Selangor Darul Ehsan, Malaysia 4 Hospital Selayang, Department of Medicine, Selangor ...
BMJ1d
A randomised controlled trial of occupational therapy for people with early rheumatoid arthritis
Background: Occupational therapy (OT) aims at improving performance of daily living tasks, facilitating successful adjustments in lifestyle, and preventing losses of function. Objective: To evaluate ...
BMJ2d
Not only synovitis but also tenosynovitis needs to be considered: why it is time to update textbook images of rheumatoid arthritis
Correspondence to Professor Annette van der Helm-van Mil, Rheumatology, Leiden University Medical Center, Leiden 2300 RC, The Netherlands; A.H.M.van_der_Helm{at}lumc.nl Rheumatoid arthritis (RA) is ...
BMJ2d
Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage
Laboratory of Gene Regulation and Signal Transduction, Departments of Pharmacology and Pathology, School of Medicine, University of California, San Diego, California, USA Correspondence to Dr Michael ...
BMJ3d
Anti-endothelial cell antibodies in systemic sclerosis
Department of Internal Medicine/Division Clinical and Experimental Immunology, University Hospital Maastricht, Maastricht, The Netherlands Correspondence to Professor J W C Tervaert, Department of ...
BMJ3d
PPARγ preservation via promoter demethylation alleviates osteoarthritis in mice
Objectives Osteoarthritis (OA) is the most common degenerative joint disease in aged population and its development is significantly influenced by aberrant epigenetic modifications of numerous OA ...
BMJ3d
Validity, reliability, and applicability of seven definitions of hip osteoarthritis used in epidemiological studies: a systematic appraisal
1 Department of General Practice, Erasmus MC, Rotterdam, The Netherlands 2 Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, The Netherlands 3 Department of Rheumatology, Erasmus MC ...
BMJ4d
Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging
1 Paris-Descartes University, Rheumatology A Department, Cochin Hospital, AP-HP, Paris, France 2 Paris-Descartes University, Radiology A Department, Cochin Hospital, AP-HP, Paris, France 3 ...
BMJ4d
Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures
The Lupus Research Unit, The Rayne Institute, Lambeth Wing, St Thomas’ Hospital, London, UK Correspondence to: Dr D P D’Cruz The Lupus Research Unit, The Rayne Institute, St Thomas’ Hospital, London ...
BMJ5d
Smoking, rheumatoid factor status and responses to rituximab
1 Department of Rheumatology, King's College London School of Medicine, London, UK 2 Department of Rheumatology, Maidstone and Tunbridge Well NHS Trust, London, UK Correspondence to Dr Abdul Khan, ...
BMJ6d
POS0894 ANTI-IL-6 THERAPY EFFECT FOR REFRACTORY JOINT AND SKIN INVOLVEMENT IN SYSTEMIC SCLEROSIS: A REAL-WORLD, SINGLE CENTER EXPERIENCE
Background: Emerging evidence during the last two decades supports a pivotal role of Interleukin 6 (IL-6) in the pathogenesis of Systemic Sclerosis (SSc). Standard immunosuppressive agents are often ...
BMJ6d
Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis
1 MRC Centre for Immune Regulation, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK Objectives In rheumatoid arthritis (RA), a ...